[1]
Singh, A., Karnik, A. and Anand, A. 2021. Prevalence of GATA-3 in invasive breast cancer and its significance in predicting response to neoadjuvant chemotherapy: a tertiary center experience. International Surgery Journal. 8, 6 (May 2021), 1833–1838. DOI:https://doi.org/10.18203/2349-2902.isj20212280.